Laura Van Metre Baum1, Emilie Bruzelius2, Mathew V Kiang3, Keith Humphreys4, Sanjay Basu5, Aaron Baum6. 1. Vanderbilt University School of Medicine, United States. Electronic address: Laura.baum@vumc.org. 2. Columbia University Joseph L. Mailman School of Public Health, United States. 3. Stanford University School of Medicine, United States. 4. Stanford University School of Medicine, United States; Veterans Affairs Palo Alto Health Care System, United States. 5. Research and Analytics, Collective Health, United States. 6. Icahn School of Medicine at Mount Sinai, United States.
Abstract
BACKGROUND: Millions of opioid and benzodiazepine prescriptions are dispensed near end-of-life. After death, patients' unused prescription pills belong to family members, who often save rather than dispose of them. We sought to quantify this exposure in Medicare beneficiaries. METHODS: We estimated the share of decedent Medicare beneficiaries who potentially left behind opioid or benzodiazepine pills at the time of death using Part D claims of a 20 % national sample of Medicare beneficiaries between 2006-2015 linked to the National Death Index. RESULTS: We estimated that 1 in 6 Medicare beneficiaries who died between 2006-2015 potentially left behind opioid pills, and 1 in 10 who died between 2013-2015 potentially left benzodiazepines as well. Leftover pills were more common among younger, dually enrolled, and lower-income beneficiaries, as well as beneficiaries living in non-urban areas and those with a history of mental illness, drug use disorders, and chronic pain. North American Natives and Non-Hispanic Whites had higher proportions than Black, Hispanic, and Asian decedents. CONCLUSIONS: Opioids and benzodiazepines are commonly left behind at death. Policies and interventions that encourage comprehensive and safe medication disposal after death may reduce risk for intra-household diversion and misuse of prescription opioids and benzodiazepines.
BACKGROUND: Millions of opioid and benzodiazepine prescriptions are dispensed near end-of-life. After death, patients' unused prescription pills belong to family members, who often save rather than dispose of them. We sought to quantify this exposure in Medicare beneficiaries. METHODS: We estimated the share of decedent Medicare beneficiaries who potentially left behind opioid or benzodiazepine pills at the time of death using Part D claims of a 20 % national sample of Medicare beneficiaries between 2006-2015 linked to the National Death Index. RESULTS: We estimated that 1 in 6 Medicare beneficiaries who died between 2006-2015 potentially left behind opioid pills, and 1 in 10 who died between 2013-2015 potentially left benzodiazepines as well. Leftover pills were more common among younger, dually enrolled, and lower-income beneficiaries, as well as beneficiaries living in non-urban areas and those with a history of mental illness, drug use disorders, and chronic pain. North American Natives and Non-Hispanic Whites had higher proportions than Black, Hispanic, and Asian decedents. CONCLUSIONS: Opioids and benzodiazepines are commonly left behind at death. Policies and interventions that encourage comprehensive and safe medication disposal after death may reduce risk for intra-household diversion and misuse of prescription opioids and benzodiazepines.
Authors: Marissa J Seamans; Timothy S Carey; Daniel J Westreich; Stephen R Cole; Stephanie B Wheeler; G Caleb Alexander; Virginia Pate; M Alan Brookhart Journal: JAMA Intern Med Date: 2018-01-01 Impact factor: 21.873
Authors: Rebecca L Haffajee; Michelle M Mello; Fang Zhang; Alan M Zaslavsky; Marc R Larochelle; J Frank Wharam Journal: Health Aff (Millwood) Date: 2018-06 Impact factor: 6.301